Exclusive: US pharma tariffs likely weeks away as Trump plans for Alaska, sources say
1. U.S. tariffs on pharmaceuticals may delay the expected announcement. 2. Focus on tariffs could influence market confidence in the healthcare sector.
1. U.S. tariffs on pharmaceuticals may delay the expected announcement. 2. Focus on tariffs could influence market confidence in the healthcare sector.
Prolonged uncertainty around tariffs can dampen investor sentiment, similar to past tariff deliberations causing market fluctuations.
Tariffs impact costs for pharmaceutical companies and can resonate through the S&P 500, affecting broader market sentiments.
Market reactions to news about tariffs often occur immediately due to investor sentiment and speculation.